مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo.
Normal view MARC view ISBD view

Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo. [electronic resource]

By:
  • Elango, Ramesh
Contributor(s):
  • Vishnubalaji, Radhakrishnan
  • Manikandan, Muthurangan
  • Binhamdan, Sarah Ibrahim
  • Siyal, Abdul-Aziz
  • Alshawakir, Yasser A
  • Alfayez, Musaad
  • Aldahmash, Abdullah
  • Alajez, Nehad M
Producer: 20201030Description: 13696 p. digitalISSN:
  • 2045-2322
Subject(s):
  • Antineoplastic Agents -- pharmacology
  • Apoptosis -- drug effects
  • Cell Cycle -- drug effects
  • Cell Line, Tumor
  • Cell Movement -- drug effects
  • Cell Proliferation -- drug effects
  • Cell Survival -- drug effects
  • Cyclin-Dependent Kinase 4 -- metabolism
  • Cyclin-Dependent Kinase 6 -- metabolism
  • Heterocyclic Compounds, 2-Ring -- pharmacology
  • Humans
  • Mitogen-Activated Protein Kinase 7 -- metabolism
  • Piperazines -- pharmacology
  • Protein Kinase Inhibitors -- pharmacology
  • Pyridines -- pharmacology
  • Thiazoles -- pharmacology
Online resources:
  • Available from publisher's website
In: Scientific reports vol. 9
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

Log in to your account to post a comment.

Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo.

APA

Elango R., Vishnubalaji R., Manikandan M., Binhamdan S. I., Siyal A., Alshawakir Y. A., Alfayez M., Aldahmash A. & Alajez N. M. (20201030). Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo. : Scientific reports.

Chicago

Elango Ramesh, Vishnubalaji Radhakrishnan, Manikandan Muthurangan, Binhamdan Sarah Ibrahim, Siyal Abdul-Aziz, Alshawakir Yasser A, Alfayez Musaad, Aldahmash Abdullah and Alajez Nehad M. 20201030. Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo. : Scientific reports.

Harvard

Elango R., Vishnubalaji R., Manikandan M., Binhamdan S. I., Siyal A., Alshawakir Y. A., Alfayez M., Aldahmash A. and Alajez N. M. (20201030). Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo. : Scientific reports.

MLA

Elango Ramesh, Vishnubalaji Radhakrishnan, Manikandan Muthurangan, Binhamdan Sarah Ibrahim, Siyal Abdul-Aziz, Alshawakir Yasser A, Alfayez Musaad, Aldahmash Abdullah and Alajez Nehad M. Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo. : Scientific reports. 20201030.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site